Literature DB >> 10787423

The phosphotyrosyl phosphatase activator gene is a novel p53 target gene.

V Janssens1, C Van Hoof, I De Baere, W Merlevede, J Goris.   

Abstract

The minimal promoter of the phosphotyrosyl phosphatase activator (PTPA) gene, encoding a regulator of protein phosphatase 2A contains two yin-yang 1 (YY1)-binding sites, positively regulating promoter activity. We now describe a role for p53 in the regulation of PTPA expression. Luciferase reporter assays in Saos-2 cells revealed that p53 could down-regulate PTPA promoter activity in a dose-dependent manner, whereas four different p53 mutants could not. The p53-responsive region mapped to the minimal promoter. Overexpression of YY1 reverses the repressive effect of p53, suggesting a functional antagonism between p53 and YY1. The latter does not involve competition for YY1 binding, but rather direct control of YY1 function. Inhibition of PTPA expression by endogenous p53 was demonstrated in UVB-irradiated HepG2 cells, both on the mRNA and protein level. Also basal PTPA levels are higher in p53-negative (Saos-2) versus p53-positive (HepG2, U2OS) cells, suggesting "latent" p53 can control PTPA expression as well. The higher PTPA levels in U2OS cells, programmed to overexpress constitutively a dominant-negative p53 mutant, corroborate this finding. Thus, PTPA expression is negatively regulated by p53 in normal conditions and in conditions where p53 is up-regulated, via an as yet unknown mechanism involving the negative control of YY1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787423     DOI: 10.1074/jbc.M909370199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Involvement of YY1 and its correlation with c-myc in NDEA induced hepatocarcinogenesis, its prevention by d-limonene.

Authors:  Tithi Parija; Bibhu Ranjan Das
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

2.  Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.

Authors:  A Zamò; J Pischimarov; M Schlesner; P Rosenstiel; R Bomben; H Horn; T Grieb; T Nedeva; C López; A Haake; J Richter; L Trümper; C Lawerenz; W Klapper; P Möller; M Hummel; D Lenze; M Szczepanowski; L Flossbach; M Schreder; V Gattei; G Ott; R Siebert; A Rosenwald; E Leich
Journal:  Leukemia       Date:  2017-08-21       Impact factor: 11.528

Review 3.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

4.  Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines.

Authors:  Lawson Eng; Irada Ibrahim-zada; Hamdi Jarjanazi; Sevtap Savas; Mehran Meschian; Kathleen I Pritchard; Hilmi Ozcelik
Journal:  BMC Med Genomics       Date:  2011-02-11       Impact factor: 3.063

5.  L-carnitine and PPARα-agonist fenofibrate are involved in the regulation of Carnitine Acetyltransferase (CrAT) mRNA levels in murine liver cells.

Authors:  Klemens Kienesberger; Aniko Ginta Pordes; Thomas Georg Völk; Reinhold Hofbauer
Journal:  BMC Genomics       Date:  2014-06-24       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.